TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models
Year: 2015
Type: article
Source: Molecular Cancer Therapeutics
Institution: Taiho Pharmaceutical (Japan)
Language: English
Topic: Heat shock proteins research
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Taiho Pharmaceutical
OpenAlex ID: W2165563508
